Combining brain stimulation and yoga for knee arthritis pain relief
Official title: Combining Transcranial Direct Current Stimulation and Yoga for Improved Pain Management for Knee Osteoarthritis: A Pilot and Feasibility Trial
Run by McMaster University · NCT06228573 · Data updated 2026-11-12
This study is testing if combining brain stimulation with yoga can help people with knee arthritis feel less pain and improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years and up |
| Sex | All |
| Enrollment | 68 (estimated) |
| Sponsor | McMaster University Academic / other |
| Locations | 3 sites (Hamilton, Ontario and 2 other locations) |
| Status | Recruiting |
| Started | October 20, 2024 |
| Main results expected | November 15, 2026 |
| Study ends | November 15, 2026 |
| Registry record updated | August 28, 2026 |
| Trial ID | NCT06228573 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are community-dwelling adults aged 45 and older with a diagnosis of knee osteoarthritis or movement-related joint pain.
✕Probably not a fit
Patients with systemic inflammatory arthritis, recent knee injections, or contraindications to tDCS may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates a novel approach to managing knee osteoarthritis pain by combining Transcranial Direct Current Stimulation (tDCS) with yoga. The researchers aim to modify neural pathways associated with pain through non-invasive brain stimulation while promoting overall well-being with yoga. Participants will be randomly assigned to receive either real tDCS plus yoga or a placebo tDCS plus yoga, allowing for a comparison of the effectiveness of this combined intervention. The goal is to improve pain management and quality of life for individuals suffering from knee osteoarthritis.
Why it matters
Potential benefit: If successful, this approach could provide a safer and more effective alternative to traditional pain management methods for knee osteoarthritis.
How similar studies have gone: This approach is novel and has not been previously tested in combination for chronic pain management in knee osteoarthritis.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * community dwelling adults from Sherbrooke, Quebec, Hamilton and London, Ontario fulfilling the NICE criteria for KOA * ≥45 years of age * Diagnosis of Knee osteoarthritis OR * Having movement-related joint pain with either no morning knee stiffness or stiffness of 30 minutes or less AND * Experiencing an average pain intensity of ≥3 /10 in the past month Exclusion Criteria: * Systemic inflammatory arthritis. * Any knee injection in the past 3 months. * Inability to independently get up and down from the floor. * Lower limb trauma or surgery within the last 6 months. * Current participation in another OA clinical trial. * Use of mobility aids. * Currently receiving care for KOA pain (e.g., physiotherapy). * Planned absences exceeding 1 week. * Contraindications to transcranial direct current stimulation (tDCS) such as neurological or neuropsychiatric conditions. * History of brain surgery or tumor. * Metallic implants. * Epilepsy or history of substance abuse or dependence. * Cochlear or ocular implant. * Presence of a pacemaker or cardiac defibrillator. * Eczema on the scalp.
Where it's running
-
McMaster University
Hamilton, Ontario, Canada Recruiting -
University of Western Ontario
London, Ontario, Canada Recruiting -
Université de Sherbrooke
Sherbrooke, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Lisa Carlesso, PhD — McMaster University
- Study coordinator: Lisa Carlesso, PhD
- Email: carlesl@mcmaster.ca
- Phone: 2896805640
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.
-
Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status
Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.
-
Lysyl Enzymes in Knee Osteoarthritis
This study tests whether blood levels of lysyl hydroxylase and lysyl oxidase differ between people with knee osteoarthritis and healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.